Vitamins, Coenzyme Q10, and Antioxidant Strategies to Improve Oocyte Quality in Women with Gynecological Cancers: A Comprehensive Review
review
OA: gold
CC0
Abstract
BACKGROUND: Gynecological cancers, including ovarian, cervical, and endometrial cancers, significantly affect both survival and reproductive health in women. Cancer treatments such as chemotherapy and radiotherapy can impair ovarian function, reducing oocyte quality and fertility potential. OBJECTIVE: This review aims to evaluate how vitamins and antioxidants can enhance fertility and fertility preservation outcomes for women diagnosed with gynecological cancers, particularly in the context of assisted reproductive technologies (ART). Standard treatments for these cancers, including hysterectomy, bilateral salpingo-oophorectomy, radiation, and chemotherapy, often compromise ovarian function and oocyte quality. This review focuses on the potential role of these interventions in improving oocyte quality, thereby supporting successful fertility preservation and ART outcomes. METHODS: A comprehensive narrative review of the current literature was conducted, examining the effects of vitamins A, C, D3, E, and Coenzyme Q10 on oocyte quality, particularly in the context of oxidative stress and inflammation induced by cancer and its treatments. RESULTS: The evidence suggests that certain vitamins and antioxidants may mitigate oxidative damage and enhance oocyte quality. Vitamin A supports cumulus-oocyte complex integrity, while vitamins C and E act as potent antioxidants, reducing oxidative stress in ovarian tissues. Vitamin D3 enhances ovarian reserve markers and modulates inflammatory cytokines. Coenzyme Q10 improves mitochondrial function and reduces DNA damage, increasing oocyte viability and fertilization potential. CONCLUSIONS: The incorporation of specific vitamins and antioxidants into fertility preservation strategies may enhance oocyte quality in women with gynecological cancers. Although the preliminary findings are promising, further research is needed to determine optimal dosages and establish standardized protocols for clinical use.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (90)
- Analysis of the Vitamin D System in Cervical Carcinomas, Breast Cancer and Ovarian Cancer via openalex
- A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations via openalex
- Follicular Proinflammatory Cytokines and Chemokines as Markers of IVF Success via openalex
- W6797989111 via openalex
- W7046800554 via openalex
- doi:10.3390/nu14235026 via openalex
- doi:10.1177/1933719112459225 via openalex
- doi:10.1111/acel.12368 via openalex
- doi:10.3945/jn.115.217620 via openalex
- doi:10.21203/rs.3.rs-2901802/v1 via openalex
- doi:10.17749/2313-7347/ob.gyn.rep.2024.541 via openalex
- doi:10.1016/s0093-691x(01)00687-2 via openalex
- doi:10.1016/j.currproblcancer.2024.101063 via openalex
- doi:10.20944/preprints202406.0503.v1 via openalex
- doi:10.1016/j.freeradbiomed.2024.01.024 via openalex
- doi:10.1093/humrep/deu079 via openalex
- doi:10.1024/0300-9831/a000634 via openalex
- doi:10.1146/annurev-pharmtox-010510-100611 via openalex
- doi:10.3390/nu14040882 via openalex
- doi:10.1262/jrd.2012-064 via openalex
- doi:10.3390/ijms25031709 via openalex
- doi:10.3390/genes12081266 via openalex
- doi:10.3390/ijms24076837 via openalex
- doi:10.3390/nu16091392 via openalex
- doi:10.3390/vetsci11080372 via openalex
- doi:10.3322/caac.21660 via openalex
- doi:10.1002/agm2.12297 via openalex
- doi:10.1016/j.fertnstert.2014.07.435 via openalex
- W2283927353 via openalex
- doi:10.1016/j.pathophys.2019.08.003 via openalex
- doi:10.15296/ijwhr.2017.08 via openalex
- W2765423037 via openalex
- doi:10.1007/s10552-008-9283-x via openalex
- doi:10.3390/nu9070719 via openalex
- doi:10.3802/kjgo.2007.18.2.93 via openalex
- doi:10.3390/cancers14061585 via openalex
- doi:10.3390/ijms231911412 via openalex
- doi:10.3390/ijms22179541 via openalex
- doi:10.1016/j.intimp.2023.111321 via openalex
- doi:10.1371/journal.pone.0183395 via openalex
- W4213254756 via openalex
- doi:10.1186/s13046-018-1017-7 via openalex
- W4225728639 via openalex
- doi:10.23736/s0031-0808.22.04680-8 via openalex
- doi:10.1002/jcp.30468 via openalex
- doi:10.26538/tjnpr/v8i9.1 via openalex
- doi:10.1007/s10552-008-9190-1 via openalex
- doi:10.3390/nu14183712 via openalex
- doi:10.1002/rmb2.12013 via openalex
- doi:10.1002/1097-4652(200010)185:1<1::aid-jcp1>3.0.co;2-o via openalex
- doi:10.7314/apjcp.2015.16.7.2981 via openalex
- doi:10.1093/biolre/ioaa174 via openalex
- W6660793329 via openalex
- W6695309280 via openalex
- doi:10.3390/ijms24119205 via openalex
- doi:10.3390/antiox11071335 via openalex
- doi:10.3390/antiox9121197 via openalex
- doi:10.1007/s10815-006-9103-8 via openalex
- doi:10.1186/s12958-018-0343-0 via openalex
- doi:10.1016/j.rbmo.2018.12.036 via openalex
- doi:10.1186/s12929-016-0253-4 via openalex
- doi:10.1093/humupd/dmw007 via openalex
- doi:10.5935/1518-0557.20210026 via openalex
- doi:10.1016/j.tice.2024.102564 via openalex
- doi:10.1093/molehr/gav017 via openalex
- doi:10.1007/s12094-015-1281-3 via openalex
- doi:10.52225/narra.v2i1.56 via openalex
- doi:10.1007/s11684-017-0575-y via openalex
- doi:10.1002/biof.1873 via openalex
- doi:10.1095/biolreprod46.3.401 via openalex
- doi:10.3390/cancers16122214 via openalex
- doi:10.4137/cmrh.s14681 via openalex
- doi:10.21037/apm-20-2201 via openalex
- doi:10.3390/nu14163401 via openalex
- doi:10.1111/jog.14659 via openalex
- doi:10.2174/0115733947275442231213050438 via openalex
- doi:10.3390/antiox9010051 via openalex
- doi:10.1016/j.freeradbiomed.2019.08.002 via openalex
- doi:10.1111/jog.12933 via openalex
- doi:10.1002/ijgo.13702 via openalex
- doi:10.1093/humrep/dew158 via openalex
- doi:10.1093/humrep/dew304 via openalex
- doi:10.1002/mrd.23420 via openalex
- doi:10.1080/19396368.2020.1718244 via openalex
- doi:10.1080/01443615.2023.2182672 via openalex
- doi:10.1038/bjc.1986.109 via openalex
- W6718520085 via openalex
- doi:10.1615/jenvpathtoxoncol.v22.i1.20 via openalex
- W6730513606 via openalex
- W6745283605 via openalex
Source provenance
- openalex
- last seen: 2026-05-14T06:50:25.104560+00:00
License: CC0
· commercial use OK